Heyman Richard A. 4
4 · Oric Pharmaceuticals, Inc. · Filed Jan 20, 2026
Insider Transaction Report
Form 4
Heyman Richard A.
Director
Transactions
- Sale
Common Stock
[F1][F2]2026-01-16$12.00/sh−3,500$42,016→ 41,800 total - Sale
Common Stock
[F1][F2][F3]2026-01-16$12.00/sh−3,200$38,415→ 213,072 total(indirect: See footnote)
Footnotes (3)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC.
- [F2]Represents the weighted average share price of an aggregate total of 6,700 shares sold in the price range of $12.00 to $12.03 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares.
Signature
/s/ Christian Kuhlen, attorney-in-fact|2026-01-20